Company Profile
Lepu Biopharma Co., Ltd. is an innovation-driven biopharmaceutical company focusing on oncology therapeutics with a strong China foundation and global vision. Our mission is to become a leading innovative company serving the unmet medical needs of cancer patients with first-in-class and best-in-class drugs. We strive to continuously develop a market differentiating pipeline by combining in-house research and development and strategic collaborations, strengthen in-house manufacturing, and commercialize our pipeline products through dedicated sales and marketing forces in China as well as via partnerships internationally.
More
Strategic Investors
  • 3
    Technology Platforms
    ADC technology platform, Antibody discovery platform, Advanced process and analytical development platform
  • 10+
    Product Candidates
    Various types of products including monoclonal antibodies, ADCs, oncolytic viruses and others.
  • 2
    Manufacturing Facilities
    Beijing 2,000L GMP-compliant antibody production line in operation. Beijing 200L oncolytic virus production line under construction. Shanghai 12,000L at the initial phase with 6,000L antibody production line to be ready for commercial production by the end of 2021
  • 18+
    Issued patents
    6 patents granted in China, 6 granted inthe U.S., 2 granted in Japan and 1 each in South Korea, Australia, Chile and Colombia, In addition, 47 pending patent applications including 8 in Mainland China, and 39 in overseas jurisdictions (such as the U.S., Japan and the European Union)
Copyright 2021 By Lepu Biopharma CO.,Ltd.
京公网安备11011702000459号京ICP备20018649号-1